Suchergebnisse - "Langer-Gould, Annette"

PubPharm (8)

1

Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region

enthalten in: JAMA neurology | 2023

von Hittle, M. | Culpepper, W. | Langer-Gould, A. | +8

CommentIn: JAMA Neurol. 2023 Jul 1;80(7):667-669. - PMID 37184874

2

Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US : A Review

enthalten in: JAMA neurology | 2021

von Amezcua, L. | Rivera, V. | Vazquez, T. | +2

3

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

enthalten in: JAMA neurology | 2020

von Luna, G. | Alping, P. | Burman, J. | +13

CommentIn: J Neurol. 2020 May;267(5):1567-1569. - PMID 32303837

4

Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis--Reply

enthalten in: JAMA neurology | 2016

von Hellwig, K. | Langer-Gould, A.

CommentOn: JAMA Neurol. 2015 Oct;72(10):1132-8. - PMID 26322399

5

Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses

enthalten in: JAMA neurology | 2015

von Hellwig, K. | Rockhoff, M. | Herbstritt, S. | +6

CommentIn: JAMA Neurol. 2016 Apr;73(4):480. - PMID 26925546

6

Association between vaccines and neuroinflammation-reply

enthalten in: JAMA neurology | 2015

von Langer-Gould, A.

CommentOn: JAMA Neurol. 2014 Dec;71(12):1506-13. - PMID 25329096

7

Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases

enthalten in: JAMA neurology | 2014

von Langer-Gould, A. | Qian, L. | Tartof, S. | +7

CommentIn: Nat Rev Neurol. 2014 Dec;10(12):673. - PMID 25385338

8

Natalizumab use during the third trimester of pregnancy

enthalten in: JAMA neurology | 2014

von Haghikia, A. | Langer-Gould, A. | Rellensmann, G. | +12

1
[1]